NCT07140835

Brief Summary

Primary Aim: Assess improvement in ergonomics and musculoskeletal discomfort with the Surgistep compared to a standard footstool.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
10

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Aug 2025

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

August 1, 2025

Completed
21 days until next milestone

First Submitted

Initial submission to the registry

August 22, 2025

Completed
4 days until next milestone

First Posted

Study publicly available on registry

August 26, 2025

Completed
1 month until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 1, 2025

Completed
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

November 1, 2025

Completed
Last Updated

August 26, 2025

Status Verified

August 1, 2025

Enrollment Period

2 months

First QC Date

August 22, 2025

Last Update Submit

August 22, 2025

Conditions

Outcome Measures

Primary Outcomes (2)

  • Rapid Entire Body Assessment (REBA) Scale Score

    The REBA (Rapid Entire Body Assessment) score, used to assess the risk of musculoskeletal disorders (MSDs) in work tasks, ranges from 1 to 15. A lower REBA score indicates a lower risk, with scores below 4 considered to have minimal risk. Higher scores indicate increased risk, with scores of 8 or more indicating a high risk that requires immediate attention and intervention

    During the surgery upto 60 minutes

  • Rapid Upper Limb Assessment (RULA) Scale Score

    The RULA (Rapid Upper Limb Assessment) scale ranges from 1 to 7, with lower scores indicating lower risk and higher scores indicating higher risk of musculoskeletal disorders.

    During the surgery upto 60 minutes

Study Arms (2)

SurgiStep Platform

EXPERIMENTAL

The surgeon will be performing the surgery by standing over the SurgiStep Platform. The duration of the usage depends on the length of the surgery being performed by the surgeon. Surgeons will be using this platform for 2 weeks, after which they will be operating on standard foot stool for 2 weeks.

Device: SurgiStep PlatformDevice: Standard Foot stool

Standard surgical practice

PLACEBO COMPARATOR

The surgeon will be performing the surgery by standing over the standard of care (foot stool). The duration of the usage depends on the length of the surgery being performed by the surgeon. Surgeons use standard foot stool for 2 weeks, and switch to SurgiStep platform for 2 weeks.

Device: SurgiStep PlatformDevice: Standard Foot stool

Interventions

The Surgistep (pedal-controlled, adjustable platform) allows real-time height adjustment during surgery. The surgeons can adjust the height of the platform.

Standard surgical practiceSurgiStep Platform

Foot stool is considered as the standard of care during surgery.

Standard surgical practiceSurgiStep Platform

Eligibility Criteria

Age36 Years - 65 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Regularly perform neurosurgical procedures (cranial/spine)
  • Willing to use both devices (multiple times each).

You may not qualify if:

  • Severe MSK conditions preventing device usage
  • Inability/refusal to participate in observation or surveys.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Stanford Health Care

Palo Alto, California, 94305, United States

Location

Study Officials

  • Atman Desai, MD

    Stanford University

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NON RANDOMIZED
Masking
NONE
Purpose
DEVICE FEASIBILITY
Intervention Model
CROSSOVER
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Clinical Professor

Study Record Dates

First Submitted

August 22, 2025

First Posted

August 26, 2025

Study Start

August 1, 2025

Primary Completion

October 1, 2025

Study Completion

November 1, 2025

Last Updated

August 26, 2025

Record last verified: 2025-08

Data Sharing

IPD Sharing
Will not share

Locations